Ning Yang

机构：Fudan University, Institute for Systems Biology, Wuhan University, Lanzhou Veterinary Research Institute, Minhang District Central Hospital, Second People Hospital of Hunan, Shenzhen Chronic Disease Prevention Center, Chinese Academy of Agricultural Sciences, Renmin Hospital of Wuhan University, Obstetrics and Gynecology Hospital of Fudan University, Hunan Institute of Mental Health, Lanzhou University · ORCID：0000-0001-9382-492X

发表论文 70 篇 · 总被引 993 次 · h-index 15

代表论文

• Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism (2022 · Cell Death and Disease · 被引 89)
• Metabolic Intervention Nanoparticles for Triple‐Negative Breast Cancer Therapy via Overcoming FSP1‐Mediated Ferroptosis Resistance (2022 · Advanced Healthcare Materials · 被引 72)
• Discovery of highly potent and selective KRASG12C degraders by VHL-recruiting PROTACs for the treatment of tumors with KRASG12C-Mutation (2023 · European Journal of Medicinal Chemistry · 被引 37)
• Discovery of novel exceptionally potent and orally active c-MET PROTACs for the treatment of tumors with MET alterations (2023 · Acta Pharmaceutica Sinica B · 被引 29)
• MAGL blockade alleviates steroid-induced femoral head osteonecrosis by reprogramming BMSC fate in rat (2024 · Cellular and Molecular Life Sciences · 被引 12)
• Licochalcone A alleviates laser-induced choroidal neovascularization by inhibiting the endothelial-mesenchymal transition via PI3K/AKT signaling pathway (2022 · Experimental Eye Research · 被引 10)